144 related articles for article (PubMed ID: 16967148)
1. [Simulation of D1 lymphadenectomy in patients submitted to D2 lymphadenectomy. Prospective study of 57 patients with gastric adenocarcinoma].
Ilias EJ; Malheiros CA; Kassab P; Castro OA
Rev Assoc Med Bras (1992); 2006; 52(4):270-2. PubMed ID: 16967148
[TBL] [Abstract][Full Text] [Related]
2. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
5. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
6. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
8. [The outcome of D2 lymphadenectomy on staging and prognosis of stomach carcinoma--a prospective study].
Fass J; Hungs M; Reinecke T; Schumpelick V
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():176-8. PubMed ID: 9101823
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
Pan Y; Liang H; Xue Q; Zhang RP; Cui QH; Liu N; Wang BG
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):376-80. PubMed ID: 18953840
[TBL] [Abstract][Full Text] [Related]
10. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
Putchakayala K; Difronzo LA
Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
[TBL] [Abstract][Full Text] [Related]
11. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
[TBL] [Abstract][Full Text] [Related]
12. [Morbidity and mortality in gastrectomy with D2 lymphadenectomy in a specialised unit].
Díaz de Liaño A; Yárnoz C; Aguilar R; Artieda C; Ortiz H
Cir Esp; 2008 Jan; 83(1):18-23. PubMed ID: 18208744
[TBL] [Abstract][Full Text] [Related]
13. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
15. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
[TBL] [Abstract][Full Text] [Related]
16. D1 versus D2 Gastrectomy for Gastric Adenocarcinoma.
Lavy R; Hershkovitz Y; Chikman B; Shapira Z; Poluksht N; Yarom N; Sandbank J; Halevy A
Isr Med Assoc J; 2015 Dec; 17(12):735-8. PubMed ID: 26897973
[TBL] [Abstract][Full Text] [Related]
17. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging.
Schmidt B; Chang KK; Maduekwe UN; Look-Hong N; Rattner DW; Lauwers GY; Mullen JT; Yang HK; Yoon SS
Ann Surg Oncol; 2013 Sep; 20(9):2991-9. PubMed ID: 23760588
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the histologically and immunohistochemically detected solitary lymph node metastases in gastric cancer.
Griniatsos J; Yiannakopoulou E; Gakiopoulou H; Alexandrou A; Dimitriou N; Karavokyros I; Felekouras E
Scand J Surg; 2011; 100(3):174-80. PubMed ID: 22108745
[TBL] [Abstract][Full Text] [Related]
19. Aggressive D2 lymphadenectomy is required for accurate pathologic staging of gastric adenocarcinoma.
Smith BR; Stabile BE
Am Surg; 2006 Oct; 72(10):849-52. PubMed ID: 17058719
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
